المؤلفون: Stephenson JJ; Institute for Translational Oncology Research, 900 West Faris Road, 3rd Floor, Greenville, SC 29605, USA., Nemunaitis J; Mary Crowley Cancer Research Centers, 1700 Pacific Avenue, Dallas, TX 75201, USA., Joy AA; Cross Cancer Institute, University of Alberta, 11560 University Avenue NW, Edmonton, AB T6G 1Z2, Canada., Martin JC; Institute for Translational Oncology Research, 900 West Faris Road, 3rd Floor, Greenville, SC 29605, USA., Jou YM; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Zhang D; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Statkevich P; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Yao SL; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Zhu Y; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Zhou H; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Small K; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Bannerji R; Merck & Co., Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA., Edelman MJ; University of Maryland Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA. Electronic address: medelman@salud.unm.edu.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2014 Feb; Vol. 83 (2), pp. 219-23. Date of Electronic Publication: 2013 Dec 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/*administration & dosage , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Pyridinium Compounds/*administration & dosage , Quinazolines/*administration & dosage, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Carcinoma, Non-Small-Cell Lung/mortality ; Cyclic N-Oxides ; Cyclin-Dependent Kinases/antagonists & inhibitors ; Disease-Free Survival ; ErbB Receptors/antagonists & inhibitors ; Erlotinib Hydrochloride ; Female ; Follow-Up Studies ; Humans ; Indolizines ; Injections, Intravenous ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Staging ; Neutropenia/etiology ; Pyridinium Compounds/adverse effects ; Pyridinium Compounds/pharmacology ; Quinazolines/adverse effects ; Quinazolines/pharmacology